# Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma

> **NCT01639612** · PHASE1 · COMPLETED · sponsor: **Henry Friedman** · enrollment: 11 (actual)

## Conditions studied

- Grade IV Malignant Glioma

## Interventions

- **BIOLOGICAL:** ALD-451

## Key facts

- **NCT ID:** NCT01639612
- **Lead sponsor:** Henry Friedman
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2016-03
- **Final completion:** 2016-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639612, "Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01639612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*